Beginning Cash: The amount of cash reported by the company on its previous statement.
Intellia Therapeutics, Inc. (NTLA) had Beginning Cash of $167.57M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$7.66M |
|
$-106.63M |
|
-- |
|
$7.66M |
|
$120.42M |
|
$-112.76M |
|
$6.13M |
|
$-106.63M |
|
$-106.63M |
|
$-106.63M |
|
$-106.63M |
|
$-106.63M |
|
$-106.63M |
|
$-112.76M |
|
$-110.68M |
|
133.48M |
|
133.48M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$527.83M |
|
$15.06M |
|
$329.33M |
|
$857.16M |
|
$79.39M |
|
-- |
|
$50.07M |
|
$129.46M |
|
$727.71M |
|
$727.71M |
|
$727.71M |
|
140.02M |
|
| Cash Flow Statement Financials | |
$-200.46M |
|
$-75.26M |
|
$229.69M |
|
|
Beginning Cash |
$167.57M |
$121.53M |
|
$-46.04M |
|
$31.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1472.26% |
|
-1472.26% |
|
-- |
|
-1392.27% |
|
-1392.27% |
|
$-202.26M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.05 |
|
86.03 |
|
-14.65% |
|
-14.65% |
|
-12.44% |
|
-14.65% |
|
$5.20 |
|
$-1.52 |
|
$-1.50 |
|